Target Price | $178.26 |
Price | $168.88 |
Potential | 5.55% |
Number of Estimates | 23 |
23 Analysts have issued a price target Procter & Gamble 2025 . The average Procter & Gamble target price is $178.26. This is 5.55% higher than the current stock price. The highest price target is $200.00 18.43% , the lowest is $156.00 7.63% . | |
A rating was issued by 28 analysts: 16 Analysts recommend Procter & Gamble to buy, 10 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2025 of 5.55% . Most analysts recommend the Procter & Gamble stock at Purchase. |
21 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $86.3b . This is 2.66% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $87.1b 3.60% , the lowest is $85.7b 1.93% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $86.3b | 2.66% |
2026 | $89.6b | 3.84% |
2027 | $93.0b | 3.82% |
2028 | $96.1b | 3.35% |
20 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $24.4b . This is 7.20% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $25.2b 10.71% , the lowest is $23.5b 3.27% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.1b | 9.60% |
---|---|---|
2025 | $24.4b | 5.61% |
2026 | $25.8b | 5.93% |
2027 | $27.4b | 6.15% |
2028 | $28.9b | 5.28% |
2024 | 27.48% | 6.95% |
---|---|---|
2025 | 28.27% | 2.87% |
2026 | 28.84% | 2.02% |
2027 | 29.49% | 2.25% |
2028 | 30.04% | 1.87% |
10 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $16.2b . This is 14.34% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.5b 16.45% , the lowest is $15.7b 10.80% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.2b | 2.03% |
---|---|---|
2025 | $16.2b | 14.34% |
2026 | $17.6b | 8.72% |
2027 | $19.1b | 8.07% |
2028 | $19.8b | 3.92% |
2024 | 16.88% | 0.43% |
---|---|---|
2025 | 18.81% | 11.41% |
2026 | 19.69% | 4.68% |
2027 | 20.50% | 4.11% |
2028 | 20.61% | 0.54% |
10 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $6.88 . This is 14.29% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $7.01 16.45% , the lowest is $6.67 10.80% .
This results in the following potential growth metrics and future valuations:
2024 | $6.02 | 2.03% |
---|---|---|
2025 | $6.88 | 14.29% |
2026 | $7.48 | 8.72% |
2027 | $8.09 | 8.16% |
2028 | $8.41 | 3.96% |
Current | 28.06 | 13.47% |
---|---|---|
2025 | 24.53 | 12.58% |
2026 | 22.57 | 7.99% |
2027 | 20.88 | 7.49% |
2028 | 20.09 | 3.78% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.89 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.60 .
This results in the following potential growth metrics and future valuations:
Current | 5.02 | 10.57% |
---|---|---|
2025 | 4.89 | 2.61% |
2026 | 4.71 | 3.70% |
2027 | 4.53 | 3.68% |
2028 | 4.39 | 3.24% |
Current | 4.72 | 12.64% |
---|---|---|
2025 | 4.60 | 2.59% |
2026 | 4.43 | 3.70% |
2027 | 4.27 | 3.68% |
2028 | 4.13 | 3.24% |
Procter & Gamble...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.